PubMed COVID-19 Clinical Care
29081 - 29090 of 44979 results found
RNAenrich: A Web Server for Non-coding RNA Enrichment
Description
MOTIVATION: With the rapid advances of RNA sequencing and microarray technologies in non-coding RNA (ncRNA) research, functional tools that perform enrichment analysis for ncRNAs are needed. On the one hand, because of the rapidly growing interest in
Prognostic factors of mortality in patients with cancer infected with COVID-19: a systematic review protocol
Description
INTRODUCTION: The COVID-19 pandemic has resulted in many cases of infection and deaths worldwide. Patients with cancer are a high-risk group for COVID-19-related death. However, a systematic summary of the prognostic factors related to mortality in
Long-term SARS-CoV-2 surveillance in wastewater and estimation of COVID-19 cases: An application of wastewater-based epidemiology
Description
The role of wastewater-based epidemiology (WBE), a powerful tool to complement clinical surveillance, has increased as many grassroots-level facilities, such as municipalities and cities, are actively involved in wastewater monitoring, and the
COVID-19 vaccination produces exercise-responsive SARS-CoV-2-specific T-cells regardless of infection history
Description
CONCLUSION: These data indicate that acute exercise mobilizes SARS CoV-2-specific T-cells that recognize spike protein and increases the redistribution of neutralizing antibodies in individuals with hybrid immunity.
Decreased incidence of Guillain-Barré syndrome during the COVID-19 pandemic: a retrospective population-based study
Description
Letter to the Editor.
Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs
Description
CONCLUSION: The recommendations of this consensus seek to optimize the care, management and treatment of PwMS in Latin America. The standardized evidence-based care of pwMS infections will allow better outcomes.
Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection
Description
CONCLUSIONS: These findings support the current strategy of heterologous boosting with injectable or inhaled Ad5-vectored SARS-CoV-2 vaccination of individuals primed with inactivated COVID-19 vaccine.
COVID-19 digital contact tracing worked - heed the lessons for future pandemics
Description
No abstract
Preventing SARS-CoV-2 infection and its severe outcomes in HIV-infected people
Description
No abstract
